BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Genocea Biosciences 

161 1st Street
Suite 2C
Cambridge  Massachusetts    U.S.A.
Phone: 617-876-8191 Fax: 617-500-0969


SEARCH JOBS




Industry
Biotechnology

Segment
Start Up
Vaccines





 Company News
Genocea Biosciences Reports Second Quarter 2014 Financial Results 8/6/2014 9:36:59 AM
Genocea Biosciences To Announce Second Quarter 2014 Financial Results On August 6, 2014 7/30/2014 10:51:38 AM
Genocea Biosciences HSV-2 Immunotherapeutic GEN-003 Elicits Significant, Durable T Cell Responses In Vaccinated Subjects 7/22/2014 11:22:33 AM
Genocea Biosciences Commences Phase 2 Dose Optimization Trial For GEN-003 HSV-2 Immunotherapy 7/21/2014 11:17:08 AM
Genocea Biosciences Elects Not To Pursue Public Offering 7/16/2014 10:40:34 AM
Genocea Biosciences Commences Public Offering Of Common Stock 7/14/2014 1:32:08 PM
Genocea Biosciences Announces Positive Top-Line 12-Month Follow-Up Data From Phase 1/2a Clinical Trial For HSV-2 Immunotherapy GEN-003 7/1/2014 9:10:25 AM
Genocea Biosciences Announces Positive Top-Line Phase 1 Results For Novel Universal Pneumococcus Vaccine Candidate GEN-004 6/23/2014 8:52:47 AM
Genocea Biosciences Reports First Quarter 2014 Financial Results 5/6/2014 7:35:22 AM
Genocea Biosciences To Announce First Quarter 2014 Financial Results On May 6, 2014 4/29/2014 10:19:06 AM
1234567